In their study of CSF3R alteration in CNL and CMML, Ouyang and colleagues found that SRSF2 and SETBP1 were associated with a worse prognosis, whereas CSF3R alteration did not affect outcomes [24]. Here, SRSF2 is linked to chronic myelomonocytic leukemia.